Through the modulation of NF‐κB, PI3K/Akt, and STAT3, as well as ROS‐mediated mitochondrial pathways, plumbagin causes apoptosis and cell cycle arrest, and inhibits metastasis in a variety of cancer types, including breast, prostate, and lung cancer. This evidence concerns the gene NFKB1 and cancer.